CA2156120A1 - Derives de substitution en 3 de 2-oxindoles, inhibiteurs de la replication virale - Google Patents

Derives de substitution en 3 de 2-oxindoles, inhibiteurs de la replication virale

Info

Publication number
CA2156120A1
CA2156120A1 CA002156120A CA2156120A CA2156120A1 CA 2156120 A1 CA2156120 A1 CA 2156120A1 CA 002156120 A CA002156120 A CA 002156120A CA 2156120 A CA2156120 A CA 2156120A CA 2156120 A1 CA2156120 A1 CA 2156120A1
Authority
CA
Canada
Prior art keywords
medicine according
thienyl
medicine
compound
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002156120A
Other languages
English (en)
Inventor
Sandra L. Silberman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of CA2156120A1 publication Critical patent/CA2156120A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
CA002156120A 1994-08-17 1995-08-15 Derives de substitution en 3 de 2-oxindoles, inhibiteurs de la replication virale Abandoned CA2156120A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29213894A 1994-08-17 1994-08-17
US08/292,138 1994-08-17

Publications (1)

Publication Number Publication Date
CA2156120A1 true CA2156120A1 (fr) 1996-02-18

Family

ID=23123389

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002156120A Abandoned CA2156120A1 (fr) 1994-08-17 1995-08-15 Derives de substitution en 3 de 2-oxindoles, inhibiteurs de la replication virale

Country Status (8)

Country Link
JP (1) JPH0859464A (fr)
KR (1) KR960006923A (fr)
CN (1) CN1123144A (fr)
AU (1) AU2859495A (fr)
CA (1) CA2156120A1 (fr)
HU (1) HUT73810A (fr)
IL (1) IL114891A0 (fr)
ZA (1) ZA956831B (fr)

Also Published As

Publication number Publication date
HU9502420D0 (en) 1995-10-30
IL114891A0 (en) 1995-12-08
ZA956831B (en) 1997-02-17
CN1123144A (zh) 1996-05-29
JPH0859464A (ja) 1996-03-05
AU2859495A (en) 1996-02-29
KR960006923A (ko) 1996-03-22
HUT73810A (en) 1996-09-30

Similar Documents

Publication Publication Date Title
EP0542795B1 (fr) Inhibiteurs de facteur de necrose tumorale
RU2420279C2 (ru) Применение ингибиторов hdac для лечения миеломы
CA2230970A1 (fr) Inhibiteur specifique de cyclo-oxygenase 2 et agent anti-inflammatoire
AU700932B2 (en) Pharmaceutical agents for the treatment of Alzheimer's disease
IE62751B1 (en) 3-substituted-2-oxindole-1-carboxamides for suppressing t-cell function
EP0543855A1 (fr) Utilisation de composes d'aryle hydroxyuree pour le traitement de l'atherosclerose
EP0237796B1 (fr) Inhibiteurs de la biosynthèse de la prostaglandine
CA2156120A1 (fr) Derives de substitution en 3 de 2-oxindoles, inhibiteurs de la replication virale
US5674870A (en) Anti-cancer uses for barbituric acid analogs
EP0373827B1 (fr) Dérivés de 5-hydroxy et 5-méthoxy-2-amino-pyrimidines comme inhibiteurs de la production d'interleukine-1
EP0425109B1 (fr) Dérivés de 3-substitués-2-oxindole comme inhibiteurs de biosynthèse d'interleukine
RU2160102C2 (ru) Применение бензидамина для лечения патологических состояний, вызванных фно
IL182710A (en) Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds
US5589510A (en) Method for inhibiting retroviral infection by administering a naphthalenesulfonic acid compound
US7097862B2 (en) Methods of inhibiting tumor necrosis factor
US5071852A (en) Derivatives of 5-hydroxy and 5-methoxy 2-amino-pyrimidines as inhibitors of interleukin-1 production
NZ235638A (en) The use of indole derivatives for treating interleukin-1 related disorders
WO2021203001A1 (fr) Procédé de traitement de patients infectés par une infection virale avec un inhibiteur de l'enzyme activant le petit modificateur de type ubiquitine
CA2143544A1 (fr) Agents pharmaceutiques pour le traitement des lesions myocardiques causees par une ischemie et par des cytokines

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued